Abbott Laboratories buy Jefferies Financial Group Inc.
Start price
18.07.25
/
50%
€104.68
Target price
18.07.26
€124.73
Performance (%)
-11.22%
Price
10:56
€92.93
Summary
This prediction is currently active. The price of Abbott Laboratories has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.22%. This prediction currently runs until 18.07.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 1.508% | 1.508% |
| iShares Core DAX® | -1.553% | -0.123% |
| iShares Nasdaq 100 | -0.386% | -0.595% |
| iShares Nikkei 225® | 1.640% | 5.468% |
| iShares S&P 500 | 0.114% | -0.217% |
Comments by Jefferies_Financial_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $145.00 price target on the stock, up previously from $143.00.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Jefferies_Financial_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€110.74
16.10.25
16.10.25
€127.63
16.10.26
16.10.26
-16.74%
10:56
10:56
